ramipril · Powder

What changed in the last 90 days

Every detected change for ramipril, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Angiotensin Converting Enzyme Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• quinapril and hydrochlorothiazide· in shortage
• quinapril hydrochloride/hydrochlorothiazide· in shortage
• quinapril hydrochloride· in shortage
• quinapril· in shortage
• captopril and hydrochlorothiazide· 1 maker
• enalapril· 1 maker
• enalapril maleate oral solution· 1 maker
• lisinopril/hctz· 1 maker
• quinapril and hydrochlorothiazide 10/12.5· 1 maker
• quinapril and hydrochlorothiazide 20/12.5· 1 maker
• quinapril and hydrochlorothiazide 20/25· 1 maker
• quinapril hcl and hydrochlorothiazide· 1 maker

Common questions

Is Ramipril in shortage right now?

No. FDA does not currently list Ramipril in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Ramipril?

25 companies have marketed Ramipril in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Ramipril cost?

The typical pharmacy pays about $0.0531 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.